Therapeutic Note(s)

Government of Ontario Logo
300mg/Vial Prolong-Rel Inj Pd-Vial Pk (ARIPIPRAZOLE)
For the maintenance treatment of schizophrenia in patients who are stabilized on oral aripiprazole who have: A history of non-adherence; AND one of the following: a) Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; OR b) Inadequate control or significant side-effects from one or more conventional depot antipsychotic agents.